Skip to main content
Mykol Larvie, MD, Radiology, Cleveland, OH

MykolLarvieMD

Radiology Cleveland, OH

Neuroradiology, Nuclear Radiology

Director of Functional Neuroimaging

Dr. Larvie is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Larvie's full profile

Already have an account?

  • Office

    9500 Euclid Avenue
    Cleveland Clinic
    Cleveland, OH 44195

Education & Training

  • Massachusetts General Hospital/Harvard Medical School
    Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiology-Diagnostic, 2004 - 2008
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 2003 - 2004
  • Harvard Medical School
    Harvard Medical SchoolClass of 2003

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2021 - 2027
  • HI State Medical License
    HI State Medical License 2019 - 2026
  • FL State Medical License
    FL State Medical License 2016 - 2025
  • MA State Medical License
    MA State Medical License 2006 - 2025
  • OH State Medical License
    OH State Medical License 2016 - 2024
  • American Board of Radiology Diagnostic Radiology
  • American Board of Radiology Neuroradiology
  • American Board of Radiology Nuclear Radiology

Publications & Presentations

PubMed

Journal Articles

  • Quantitative Positron Emission Tomography–Guided Magnetic Resonance Imaging Postprocessing in Magnetic Resonance Imaging–Negative Epilepsies  
    William Bingaman, Guiyun Wu, Mykol Larvie, Imad M Najm, Stephen E Jones, Andreas V Alexopoulos, Epilepsia

Press Mentions

  • New Drug May Help Diagnose MS More Accurately
    New Drug May Help Diagnose MS More AccuratelyJanuary 30th, 2020
  • FDA Approves Clinical Trial for ‘Missing Link’ Imaging Agent Aimed at Faster MS Diagnosis
    FDA Approves Clinical Trial for ‘Missing Link’ Imaging Agent Aimed at Faster MS DiagnosisJanuary 28th, 2020

Professional Memberships